TrialEuropean radiology2016
Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation.
J Khalifa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papertrialcites it